NASDAQ:ADVB - Nasdaq - US00752P1049 - Common Stock - Currency: USD
0.3859
-0.05 (-11.08%)
The current stock price of ADVB is 0.3859 USD. In the past month the price decreased by -41.71%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 28.51 | 42.74B | ||
COO | COOPER COS INC/THE | 17.93 | 13.88B | ||
SOLV | SOLVENTUM CORP | 12.17 | 12.53B | ||
ALGN | ALIGN TECHNOLOGY INC | 14.84 | 10.12B | ||
BLCO | BAUSCH + LOMB CORP | 34.38 | 5.11B | ||
LNTH | LANTHEUS HOLDINGS INC | 10.97 | 5.03B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 23.08 | 4.99B | ||
HAE | HAEMONETICS CORP/MASS | 16.65 | 3.66B | ||
ICUI | ICU MEDICAL INC | 18.48 | 3.18B | ||
XRAY | DENTSPLY SIRONA INC | 8.36 | 2.80B | ||
UFPT | UFP TECHNOLOGIES INC | 26.99 | 1.86B | ||
STAA | STAAR SURGICAL CO | N/A | 1.34B |
Advanced Biomed, Inc. operates as a holding company with interests in developing biochip technologies. The company is headquartered in Reno, Nevada and currently employs 40 full-time employees. The company went IPO on 2025-03-06. The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.
ADVANCED BIOMED INC
401 Ryland St, Ste 200-A
Reno NEVADA US
Employees: 40
Phone: 1862120510823
The current stock price of ADVB is 0.3859 USD. The price decreased by -11.08% in the last trading session.
The exchange symbol of ADVANCED BIOMED INC is ADVB and it is listed on the Nasdaq exchange.
ADVB stock is listed on the Nasdaq exchange.
ADVANCED BIOMED INC (ADVB) has a market capitalization of 8.35M USD. This makes ADVB a Nano Cap stock.
ADVANCED BIOMED INC (ADVB) currently has 40 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ADVB does not pay a dividend.
ADVANCED BIOMED INC (ADVB) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.25).
The outstanding short interest for ADVANCED BIOMED INC (ADVB) is 1.54% of its float. Check the ownership tab for more information on the ADVB short interest.
ChartMill assigns a fundamental rating of 1 / 10 to ADVB. ADVB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months ADVB reported a non-GAAP Earnings per Share(EPS) of -0.25. The EPS increased by 25.45% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -64.4% | ||
ROE | -129.24% | ||
Debt/Equity | 0 |